Milestones

Acceptibility in principle of Bivalent types 1 &3 oral poliomyelitis vaccine I.P. (bOPV1&3) produced by Haffkine Bio-Pharmaceutical Corporation Ltd. for purchase by UN agencies.

The Company recorded a highest ever group tunover of approx, Rs 183 Crores which was the significant achievement in the annals of the Sales & Marketing history of the company which was possible only the receipt of orders from UNICEF for tOPV & mOPV1 in significant quantities.

company hase Initiated the process of revamping of the Pharmaceutical dept., at HBSCL, ATS, Pimpri & HAPL Jalgaon to comply with revised Schedule 'M, GMP requirement Company obtained UN Accreditation for mOPV1

Revamping of OPV facility at par with the guidelines for UN Pre-qualification accomplished Experimental batches of Acetone killed Typhoid vaccine cleared by CDL, Kasuali.

Successful completion of Lyophilization project at ATS, Pimpri.

Restart of Anti Rabies Serum manufacturing initiated.

Obtaining UNICEF order for supply of oral polio vaccine.

Implementation of WHO-GMP guidelines for certification for oral polio vaccine facilities.

Vermiculture from horse dung at Pimpri.

Launching of Lyophilisation project at Pimpri